RMAKAL Trademark

Trademark Overview

On Friday, September 19, 2014, a trademark application was filed for RMAKAL with the United States Patent and Trademark Office. The USPTO has given the RMAKAL trademark a serial number of 86400220. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2017. This trademark is owned by Tarsa Therapeutics, Inc.. The RMAKAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biopharmaceutical products to treat and prevent bone disease and bone conditions in the nature of osteoporosis, osteopenia, osteoarthritis, vertebral fragility fractures, bone pain due to malignancy and phantom limb pain
rmakal

General Information

Serial Number86400220
Word MarkRMAKAL
Filing DateFriday, September 19, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 17, 2015

Trademark Statements

Goods and ServicesPharmaceutical and biopharmaceutical products to treat and prevent bone disease and bone conditions in the nature of osteoporosis, osteopenia, osteoarthritis, vertebral fragility fractures, bone pain due to malignancy and phantom limb pain

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 29, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTarsa Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103
Party NameTarsa Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19103

Trademark Events

Event DateEvent Description
Monday, May 15, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 15, 2017ABANDONMENT - NO USE STATEMENT FILED
Wednesday, October 19, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 18, 2016EXTENSION 3 GRANTED
Tuesday, September 13, 2016EXTENSION 3 FILED
Tuesday, September 13, 2016TEAS EXTENSION RECEIVED
Friday, April 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 7, 2016EXTENSION 2 GRANTED
Thursday, March 3, 2016EXTENSION 2 FILED
Wednesday, April 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2016TEAS EXTENSION RECEIVED
Thursday, October 8, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2015EXTENSION 1 GRANTED
Thursday, October 1, 2015EXTENSION 1 FILED
Tuesday, October 6, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 1, 2015TEAS EXTENSION RECEIVED
Tuesday, April 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 14, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 12, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 9, 2015EXAMINER'S AMENDMENT ENTERED
Friday, January 9, 2015ASSIGNED TO LIE
Friday, January 9, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 9, 2015EXAMINERS AMENDMENT E-MAILED
Friday, January 9, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 6, 2015ASSIGNED TO EXAMINER
Monday, September 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, September 23, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

rmakal bone pain fragility vertebral osteoarthritis fractures limb malignancy osteopenia phantom